跳至主要内容
临床试验/NCT02562079
NCT02562079已完成不适用

Vasculopathy, Inflammation and Systemic Sclerosis: The Role of Endothelial Cell Activation and OX40/OX40L in Modulation of T Lymphocyte Activation

University Hospital, Bordeaux2 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2012年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
350
试验地点
2
主要终点
Assessment of OX40L expression in endothelial cells and skin biopsies.

研究概览

简要总结

It is a study of basic research with mechanistically objectives and including clinical biological samples.

详细描述

Systemic sclerosis (SSc) is a rare and severe disease characterised by a fibrotic process and an incompletely elucidate physiopathology. Several shared featured have been identified between SSc and another autoimmune disease, the systemic lupus erythematous (SLE) as an interferon-alpha signature, the role of platelets and the polymorphism of OX40 ligand (OX40L). In SLE, OX40L has been shown highly linked to the active form of the disease, was increased by the CD40L of platelets and induced the CD8 cytotoxicity while inhibiting the suppressive functions of regulator T lymphocytes. The third main factor of the SSc physiopathology apart from autoimmunity and fibrosis is the vasculopathy with an important role of endothelial cells (EC). They turned out to be half-professional antigen presenting cells and can modulate the adaptive immunity.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age from 18 to
  • SSc diagnosed according to the American College of Rheumatology (ACR) criteria.
  • With skin manifestations since less than 10 years.
  • Localised sclerosis (LSc) diagnosed, morphea type.

排除标准

  • Age inferior to 18 or upper than
  • Skin manifestations since more than 10 years.
  • Haemostasis diseases (independent from treatments).
  • Stem cell transplant.
  • Immunosuppressive treatments in the last 6 months.
  • Associate autoimmune disease.

研究组 & 干预措施

subjects Sc

Experimental

干预措施: Blood samples (Biological)

subjects SSc diagnosed

Experimental

干预措施: Blood samples (Biological)

subjects SSc diagnosed

Experimental

干预措施: Biopsy (Biological)

subjects Localised sclerosis diagnosed

Experimental

干预措施: Blood samples (Biological)

subjects Localised sclerosis diagnosed

Experimental

干预措施: Biopsy (Biological)

结局指标

主要结局

Assessment of OX40L expression in endothelial cells and skin biopsies.

时间窗: Day 1

次要结局

未报告次要终点

研究者

发起方
University Hospital, Bordeaux
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验